Cargando…
Emerging Signal Regulating Potential of Genistein Against Alzheimer’s Disease: A Promising Molecule of Interest
Alzheimer’s disease (AD) is a progressive, irreversible brain disorder characterized by pathological aggregation of the amyloid-β peptide (Aβ) and tau protein; both of these are toxic to neurons. Currently, natural products are regarded as an alternative approach to discover novel multipotent drugs...
Autores principales: | Uddin, Md. Sahab, Kabir, Md. Tanvir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6763641/ https://www.ncbi.nlm.nih.gov/pubmed/31620438 http://dx.doi.org/10.3389/fcell.2019.00197 |
Ejemplares similares
-
nCOVID-19 Pandemic: From Molecular Pathogenesis to Potential Investigational Therapeutics
por: Kabir, Md. Tanvir, et al.
Publicado: (2020) -
Molecular Insights Into Therapeutic Potential of Autophagy Modulation by Natural Products for Cancer Stem Cells
por: Rahman, Md. Ataur, et al.
Publicado: (2020) -
Molecular Insight into the Therapeutic Promise of Flavonoids against Alzheimer’s Disease
por: Uddin, Md. Sahab, et al.
Publicado: (2020) -
p53 Modulation of Autophagy Signaling in Cancer Therapies: Perspectives Mechanism and Therapeutic Targets
por: Rahman, Md Ataur, et al.
Publicado: (2022) -
The Potential of Small Molecules to Modulate the Mitochondria–Endoplasmic Reticulum Interplay in Alzheimer’s Disease
por: Dentoni, Giacomo, et al.
Publicado: (2022)